|
|
Volumn 296, Issue 16, 2006, Pages 1951-1952
|
|
Targeted cancer therapies lagging: Better trial design could boost success rate
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
IMATINIB;
TRASTUZUMAB;
BREAST METASTASIS;
CANCER THERAPY;
CHRONIC MYELOID LEUKEMIA;
CLINICAL RESEARCH;
CLINICAL TRIAL;
HEALTH PROGRAM;
HUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
TREATMENT FAILURE;
|
|
EID: 33750327832
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.296.16.1951 Document Type: Short Survey |
|
Times cited : (13)
|
|
References (0)
|